SNGX: Second Confirmatory Phase 3 Trial of HyBryte in CTCL to Initiate Before End of 2024
⬆ $Soligenix (SNGX)$ - On May 10, 2024, Soligenix, Inc. (SNGX) announced financial results for the first quarter of 2024 and provided a business update. The company... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/sngx-second-confirmatory-phase-3-trial-of-hybryte-in-ctcl-to-initiate-before-end-of-2024?utm_source=tiger_community By Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community On Soligenix (SNGX):- https://www.smartkarma.com/entities/soligenix-inc?utm_source=tiger_community